Pharmaceutical Wholesale Services

Description

The Pharmaceutical Wholesale Services market continues to grow with new products becoming available and increasing demand with more patients being treated each year. With certain products only made available through specified pharmaceutical wholesalers, trusts typically have arrangements with all four of the major players in the market in order to access all products they require. This framework agreement utilises the national service specification for pharmaceutical wholesale services and the national key performance indicators. The scope of the agreement remains fundamentally unchanged from the outgoing framework with a selection of refinements based on learnings over the previous framework period. This framework agreement is for the provision of safe, legal, efficient and cost-effective pharmaceutical wholesale services comprising the delivery of medicines and other pharmaceutical products to Participating Authorities. The scope includes a requirement for the suppliers to work with Trusts, to meet the needs of the changing landscape such as seven day working or projects which integrate clinical pharmacy services and support risk avoidance and clinical governance agendas. EoECPH work collaboratively with the HDA (Healthcare Distribution Association) to develop how services are delivered, including involvement from regulatory bodies (MHRA). Projects include optimisation of existing digital functionality including adoption of e-invoicing processes.